Popular topics to explore
India-Uzbekistan Target Doubling Bilateral Trade with New Strategic Business Partnership
At the India-Uzbekistan Business Forum in New Delhi, Union Minister of Commerce and Industry Piyush Goyal urged businesses from both nations to co-invest, co-manufacture, and co-innovate, aiming to double bilateral trade within three years.…
Market Performance
Source: NSE The Nifty 50 advanced 1.09% to close at 24,334.30, rebounding strongly after the previous session’s subdued performance on broad-based buying across key sectors. The index opened at 24,127.60, touched an intraday low of 24,099…
Prabhudas Lilladher Maintains Accumulate on Dr Reddy's
Prabhudas Lilladher maintained Accumulate on Dr Reddy's with a ₹1,400 target cutting FY27 estimates by 5% after the company halted Semaglutide supplies due to API impurity issues. Resolution expected by October November 2026. FY28 estimates…
9th Jul · SEBI-Registered Analyst
Currency Grow (CA & SEBI Reg IA Omkar Bhutada) · 9th Jul
SPARC spent almost 18 months inside a broad consolidation (~₹115–255).
SPARC
Longer consolidations generally produce stronger moves once they resolve.
✅ 2. Clean Resistance Breakout
The major resistance around ₹255 has been broken decisively.
Weekly candle has closed well above resistance.
✅ 3. Strong Mo…
SPARC Much more upside
• **SPARC has broken out of a symmetrical triangle**, signaling that the recent consolidation after a strong uptrend may be ending. The breakout candle is accompanied by strong price expansion, improving the probability of trend continuatio…
Concord Biotech Gets USFDA Approval Why Regulatory Clearances Can Be a Major Stock Market Trigger
Concord Biotech received USFDA approval for its Mycophenolate Mofetil Oral Suspension, an immunosuppressant drug used to prevent organ rejection in kidney, liver, and heart transplant patients. The approval was granted through the company's…
SPARC Breakout clearly seen in the chart
25th May · SEBI-Registered Analyst
Currency Grow (CA & SEBI Reg IA Omkar Bhutada) · 25th May
Multi-Signal Breakout on a Fundamentally Strong Pharma Stock!
SPARC
A powerful breakout setup is emerging after a long consolidation phase. Price has finally moved above a major resistance zone with strong momentum, indicating that accumulation may be transitioning into expansion.
Technical View:…
Pharma Turns Defensive Favourite
Pharma stocks outperformed again as investors shifted toward defensive sectors amid global uncertainty and volatile crude prices. Export-focused companies are also benefiting from rupee weakness and stable US demand.
SPARC , CIPLA and !…
SPARC share price in focus: Brokerages stay bullish post Q4, see up to 12% upside as profit jumps 26% - Check target
Sun Pharma Share Price Target 2026: Sun Pharmaceutical Industries Ltd. share price will remain in focus after brokerages largely retained a positive stance following its Q4FY26 results, highlighting growth in India and specialty segments de…
25th May · SEBI-Registered Analyst
Algobazar- Data driven Wealth Management · 25th May
Daily Index View : BANKNIFTY as on 25/05/2026
1. Market Trend PROBABILITY 🚨 Current Market Trend: Positive 🚀 5% 🔍 Key Level to Watch: 53544 🔄 Current Market Surface: The trend will stay Positive until the market stay above 53544 That’s 512 points away from the last…
23rd May · SEBI-Registered Analyst
Currency Grow (CA & SEBI Reg IA Omkar Bhutada) · 23rd May
Looking at SPARC again with the marked range, I’d refine the view slightly. The character of the breakout candle matters here.
SPARC
What changed:
Massive weekly expansion candle (~28% move) directly into resistance
Price has now essentially closed at/above the 15–16 month range ceiling (~₹205)
This is no longer only a “candidate” setup — it is entering active…
19th May · SEBI-Registered Analyst
Algobazar- Data driven Wealth Management · 19th May
Daily Index View : BANKNIFTY as on 19/05/2026
1. Market Trend PROBABILITY 🚨 Current Market Trend: Positive 🚀 -5% 🔍 Key Level to Watch: 53954 🔄 Current Market Surface: The trend will stay Positive until the market stay above 53954 That’s 417 points away from the last…
8th May · SEBI-Registered Analyst
Currency Grow (CA & SEBI Reg IA Omkar Bhutada) · 8th May
Breakout Setup in Pharma Space – SPARC
SPARC
SPARC is showing a strong multi-month consolidation breakout on the weekly timeframe.
Key observations from the chart:
Price has been consolidating in a broad range between approximately ₹110–₹179 for several months.
This week, t…
Trump Slaps 100% Tariff on Branded Pharma Imports: Sun Pharma and Glenmark Most Exposed Among Indian Firms
US President Donald Trump has signed an executive order imposing up to 100% tariffs on imported patented and branded pharmaceutical products, along with their active pharmaceutical ingredients (APIs), citing national security and the need t…
26th Mar · SEBI-Registered Analyst
Investment Insights with Adarsh · 26th Mar
Sun Pharma Advanced Research Company Ltd – Stock Overview and Business Analysis
SPARC
Sun Pharma Advanced Research Company Ltd (SPARC) is a pharmaceutical research and development company focused on discovering and developing new drug molecules. It is a part of the Sun Pharma group and primarily works on innovative t…
Semaglutide War Heats Up in India: Zydus & Sun Pharma Launch Affordable Options
Key Highlights • Zydus launched Semaglutide under SEMAGLYN™, MASHEMA™, ALTERME™️ • Monthly cost around ₹2,200, improving affordability • Features reusable multi-dose pen for better convenience and adherence • Approved by DCGI for Type 2 Di…
SPARC
SPARC Is at multi-year support level, which is a trend line drawn from lows of 2008. Every time this stock has tested this trend line, it has gone on to gain almost 20 to 30%. So as of now expect a short to midterm reversal in this stock…
The Dollar Never Dies It Just Moves in Waves
The dollar doesn’t collapse or dominate forever; it rises and falls in cycles, driven by trust, crises, and lack of alternatives. Body (Learning Post) Every few years, the same question returns: Is the dollar losing control of the world?…
IN BUDEGT INR400B ELECTRONIC COMPONENT + 7 HIGH SPEED RAILWAY CORRIDOR + INR100B BIO-PHARMA SHKTI 🌟♻️ FOCUS STOCKS ***** COMPONENT 🔸MICEL 🔸MOSCHIP 🔸DIXON 🔸SPEL 🔸SBCL 🔸BEL 🔸TATAELXSI 🔸SAKSOFT ***** SPEED RAILWAY CORRIDOR ♦️RAIL…
